The purpose of this study is to evaluate the safety and effectiveness of ATryn, for the treatment of early onset preeclampsia (highblood pressure during pregnancy). ATryn is is currently approved by the Food and Drug Administration (FDA) and is used to prevent blood…
The purpose of this research is to find out whether it is safe to shorten the length of time that people at high risk for bleeding take blood thinners after being treated with a coronary stent.